We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$945M
AUM Growth
+$1.15M
Cap. Flow
-$24.5M
Cap. Flow %
-2.6%
Top 10 Hldgs %
29.99%
Holding
260
New
7
Increased
47
Reduced
116
Closed
12

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$4.57M
2
DD icon
DuPont de Nemours
DD
+$4.17M
3
WAB icon
Wabtec
WAB
+$4.11M
4
FDX icon
FedEx
FDX
+$2.83M
5
WFC icon
Wells Fargo
WFC
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 19.97%
2 Financials 14.77%
3 Technology 14.23%
4 Industrials 13.54%
5 Energy 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
201
Freeport-McMoran
FCX
$97.2B
$221K 0.02%
19,009
CAH icon
202
Cardinal Health
CAH
$55.8B
$218K 0.02%
4,632
SBUX icon
203
Starbucks
SBUX
$121B
$218K 0.02%
+2,600
New +$204K
CHD icon
204
Church & Dwight Co
CHD
$24.4B
$213K 0.02%
2,920
AON icon
205
Aon
AON
$76.1B
$212K 0.02%
+1,100
New +$199K
MER.PRK
206
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$210K 0.02%
8,000
NRT
207
North European Oil Royalty Trust
NRT
$80.9M
$207K 0.02%
29,199
WTM icon
208
White Mountains Insurance
WTM
$5.35B
$204K 0.02%
+200
New +$192K
NFLX icon
209
Netflix
NFLX
$308B
$202K 0.02%
5,500
-130
-2% -$4.69K
BBT.PRE.CL
210
DELISTED
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
$201K 0.02%
8,000
WHWK
211
Whitehawk Therapeutics
WHWK
$233M
$91K 0.01%
6,667
OVV icon
212
Ovintiv
OVV
$16.6B
$54K 0.01%
2,118
-777
-27% -$24.2K
MTNB icon
213
Matinas BioPharma
MTNB
$1.67M
$15K ﹤0.01%
350
HGT
214
DELISTED
Hugoton Royalty Trust
HGT
$6K ﹤0.01%
17,500
ALB icon
215
Albemarle
ALB
$15.2B
-2,500
Closed -$205K
C icon
216
Citigroup
C
$225B
-9,017
Closed -$561K
CVE icon
217
Cenovus Energy
CVE
$52.7B
-11,725
Closed -$102K
IAU icon
218
iShares Gold Trust
IAU
$67.4B
-9,400
Closed -$233K
VOD icon
219
Vodafone
VOD
$37.4B
-12,965
Closed -$235K
WBA
220
DELISTED
Walgreens Boots Alliance
WBA
-7,344
Closed -$465K
XBI icon
221
State Street SPDR S&P Biotech ETF
XBI
$10.1B
-2,375
Closed -$215K
CDK
222
DELISTED
CDK Global, Inc.
CDK
-3,667
Closed -$216K
LLL
223
DELISTED
L3 Technologies, Inc.
LLL
-1,675
Closed -$346K

Similar funds

Neville Rodie & Shaw's Q2 2019 Portfolio in Review

As of Q2 2019, Neville Rodie & Shaw held 260 positions worth $945M, up 0.12% from $944M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw's Q2 2019 filing shows 7 new, 47 increased, 116 reduced and 12 closed positions. Its largest new stake was Dow Inc: 72,445 shares worth $3.57M. The largest sale was ExxonMobil, an estimated $4.57M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

  • Neville Rodie & Shaw's largest Q2 2019 buy was Dow Inc: 72,445 shares worth $3.57M.
  • Neville Rodie & Shaw added most to Anadarko Petroleum in Q2 2019, an estimated $2.67M increase.
  • Neville Rodie & Shaw's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $4.57M.
  • Neville Rodie & Shaw fully exited Citigroup in Q2 2019, selling an estimated $561K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $945M portfolio in Q2 2019.
  • Neville Rodie & Shaw opened 7 new positions and closed 12 in Q2 2019.
  • Neville Rodie & Shaw's portfolio value rose 0.12% quarter-over-quarter to $945M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2019, filed 1 Jul 2019.